This meta-analysis concludes that beta-blocker therapy does not reduce major adverse cardiovascular events in patients with preserved left ventricular ejection fraction after myocardial infarction without other indications for...
Most Recent Articles
Stroke Prevention After AF Ablation with Risk Factors
This trial found that rivaroxaban did not significantly lower the incidence of stroke, systemic embolism, or new covert embolic stroke compared to aspirin in patients with stroke risk factors after successful catheter ablation...
Alirocumab’s Impact on Coronary Artery Plaque After Heart Transplant
The CAVIAR trial found that alirocumab, in addition to statin therapy early after heart transplantation, safely lowered LDL-C but did not reduce coronary artery plaque progression after one year in patients with low baseline LDL...
Early-Life Blood Pressure Management for Cardiac Health
This study found that higher life-course blood pressure, steeper increases, and greater cumulative burden are associated with lower myocardial perfusion at age seventy-seven, linking to higher MACE odds and fibrosis burden.
Hemodynamic and Anatomical Evaluation of HeartMate 3 in HFpEF
This study indicates that the HeartMate 3 in a left atrial to aortic configuration may relieve pulmonary congestion in some heart failure with preserved ejection fraction patients, contingent on careful pre-surgical anatomical...